Details of Authorized Persons under Regulation 30(5) of the SEBI LODR Regulations, 2015
Closure of Trading Window
Disclosure under Regulation 30 of SEBI Listing Regulations
Intimation of Analyst /Institutional Investors Meeting
Aarti Drugs Limited Announces Leadership Transition to Strengthen Governance and Ensure Long-term Strategic Growth
Change in Directorate
Financial Results for the quarter ended June 30, 2026
Financial Results for the quarter ended June 30, 2026
Q1 Earning Conference Call